Impingement Syndrome Market is Expected to Grow at a CAGR over 6.8% from 2017 to 2023

Pune, India, September, 2017 /MRFR Press Release/- Market Research Future has a half cooked research report on the global impingement syndrome market.

Market Highlights

Subacromial impingement syndrome is a common cause of shoulder pain. The management of subacromial impingement syndrome including indications for non-operative management, advanced imaging, and operative management. The global impingement syndrome market is majorly driven by the increasing geriatric population, increasing prevalence orthopedic diseases and rapidly increasing demand for better treatment. According to Department of Economic and Social Affairs Population Division, globally, the number of adults aged over 60 years was 841 million people in 2013. Moreover, adoption of deskbound lifestyle, poor diet and lack of exercise have fuelled the prevalence of bone disorders thereby propelling the market growth. However, high cost of the treatment and lack of awareness may slow the growth of the market.

The global impingement syndrome market is expected grow at a steady CAGR of ~6.8% during the forecasted period.

Taste the market data and market information presented through more than 115 market data tables and figures spread over 110 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “impingement syndrome market research report–Global forecast till 2023.”

Major Players in the Impingement Syndrome Market

Some of the key players in the global market are ATOS Klinik Heidelberg GmbH & Co. KG (Germany), DePuy Synthes (US), Johnson & Johnson Services, Inc. (US), Stryker Corporation (US), Medtronic (Ireland), Smith & Nephew (UK), B. Braun Melsungen AG (Germany), Abbott (US), Immediate Media Company Ltd. (US).

Regional Analysis

The global impingement syndrome market consists of four regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa.

America accounts for the largest impingement syndrome market owing to constantly increasing geriatric population, desk-bound, and increasing government support for research.

Europe holds the second position in the market, which is followed by Asia Pacific. Asia Pacific is expected to be the fastest growing region for impingement syndrome market. Increasing geriatric population, rising healthcare expenditure and increasing prevalence of orthopedic diseases drives the growth of the market.

According to Asian Development Bank, by 2025, Asia's elderly population is projected to reach nearly 923 million. Additionally, adoption of deskbound lifestyle in Asian countries is the major reason for developing orthopedic problem.

On the other hand, the Middle East & Africa has the least market for the impingement syndrome market. The Middle East & Africa is expected witness least market share due to less development in healthcare services such as new and advanced treatment methods in healthcare domain.

Segmentation

The global impingement syndrome market is segmented on the basis of types, diagnosis, treatment, and end users. On the basis of types, the market is segmented into structural impingement, and functional impingement.

On the basis of diagnosis, the market is segmented into physical examination, imaging, and other. Imaging is further segmented into ultrasonography, arthrography and MRI.

On the basis of treatment, the market is categorized into drug treatment, non-pharmacological treatment, and surgery. Drug treatment is further segmented into corticosteroid, local anesthetic, NSAIDs, and other. Non-pharmacological treatment is further segmented into joint mobilization, interferential therapy, acupuncture, soft tissue therapy, therapeutic taping, rotator cuff strengthening, and other. Surgery segment is sub segmented into arthroscopic surgery, open surgery and others.

On the basis of end user, the market is segmented into hospitals, physical therapists, and others.

Access Report Details @  https://www.marketresearchfuture.com/reports/impingement-syndrome-market-4354